Curanex Pharmaceuticals Inc Common Stock (CURX) vs Ensysce Biosciences, Inc. (ENSC)
A side-by-side comparison of Curanex Pharmaceuticals Inc Common Stock and Ensysce Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CURX
Curanex Pharmaceuticals Inc Common Stock
$4.96HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ENSC
Ensysce Biosciences, Inc.
$0.42HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CURX vs ENSC
growth of $100 · dividends reinvested · last 1yCURX -93.8% (-93.8%/yr)ENSC -79.6% (-79.6%/yr)ENSC compounded faster over this window
CURX ENSC
CURX vs ENSC: by the numbers
- •CURX is the larger company ($7M vs $6M market cap).
- •Both run net losses; CURX's is the smaller (0.00% vs -1084.23% net margin).
Metrics side by side
Valuation
| Metric | CURX | ENSC |
|---|---|---|
| P/S ratio | N/A | 5.53 |
| P/B ratio | 1.47 | N/A |
Profitability
| Metric | CURX | ENSC |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | -1084.23% |
| ROE | -218.65% | N/A |
| ROIC | -208.39% | N/A |
Growth (annualized)
| Metric | CURX | ENSC |
|---|---|---|
| Total return CAGR (5Y) | N/A | -86.22% |
Go deeper
Dig into the metrics
Curanex Pharmaceuticals Inc Common Stock ROEEnsysce Biosciences ROECuranex Pharmaceuticals Inc Common Stock operating marginEnsysce Biosciences operating marginCuranex Pharmaceuticals Inc Common Stock revenue growthEnsysce Biosciences revenue growthCuranex Pharmaceuticals Inc Common Stock free cash flowEnsysce Biosciences free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.